Pharmaceutical giant Takeda sets science-based net zero goal for 2040
Japanese firm secures approval from Science Based Targets initiative to eradicate emissions from its core business by 2040
Japanese pharmaceutical giant Takeda has become the latest global corporate to secure independent approval for its 1.5C climate action strategy from the Science Based Targets Initiative (SBTI), as it yesterday...
More on Net Zero Now
More news
Mark Carney responds to mounting criticism of 'net zero' claims
Carney concedes avoided emissions do not count toward science-based net zero targets, despite previously claiming asset manager Brookfield is 'net zero today' due to its investments in renewables
Global Briefing: Bangladesh drops plans for nine new coal plants
SEC climate disclosure plans, hydrogen developments, and climate-committed K-Pop are to the fore in this week's Global Briefing
Digging into the complex, confusing, and contentious world of soil carbon offsets
Jim Giles explores the deep divisions that are shaping the emerging field of soil-based offsets
UN: Weak 2030 national climate plans put world 'very far' from meeting Paris goals
UN urges countries to submit tougher climate plans to meet Paris goals and prevent climate catastrophe
